LTRN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lantern Pharma Inc (LTRN) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment at this time. The stock lacks strong positive catalysts, has weak financial performance, and no significant trading signals or trends to support a buy decision.
The MACD is slightly positive at 0.0925 but contracting, RSI is neutral at 45.087, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level of 2.37, with key support at 2 and resistance at 2.741. Overall, the technical indicators suggest a neutral to weak outlook.
NULL identified. There is no recent news, no significant insider or hedge fund activity, and no recent congress trading data.
The stock also has a high implied volatility (342.12%) and a low probability of significant positive movement in the short term (-1.32% in the next week).
In 2025/Q4, the company reported no revenue growth (0% YoY), a significant drop in net income (-30.65% YoY), and a decline in EPS (-33.33% YoY). Gross margin remains at 0%. The financials indicate poor growth trends and weak profitability.
No analyst rating or price target data is available for LTRN, making it difficult to gauge Wall Street sentiment.
